{"id":"https://openalex.org/W2284556239","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2040","title":"Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study","display_name":"Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study","publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W2284556239","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2040","mag":"2284556239"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.2040","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2040","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.2040","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049181098","display_name":"Sophia Frentzas","orcid":"https://orcid.org/0000-0002-6917-9737","observed_orcids":["https://orcid.org/0000-0002-6917-9737"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"S. N. Frentzas","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110346854","display_name":"Morris D. Groves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"M. D. Groves","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060729173","display_name":"Jorge Barriuso","orcid":"https://orcid.org/0000-0002-5641-9105","observed_orcids":["https://orcid.org/0000-0002-5641-9105"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"J. Barriuso","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Harris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"D. Harris","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Reardon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"D. Reardon","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077915530","display_name":"Morgan Curtis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"M. C. Curtis","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046110397","display_name":"A. Benjamin Suttle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"A. B. Suttle","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100736388","display_name":"Bo Ma","orcid":"https://orcid.org/0000-0003-4948-4897","observed_orcids":["https://orcid.org/0000-0003-4948-4897"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"B. Ma","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011428941","display_name":"Joanne J. Lager","orcid":"https://orcid.org/0000-0001-9104-1040","observed_orcids":["https://orcid.org/0000-0001-9104-1040"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"J. J. Lager","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"J. S. de Bono","raw_affiliation_strings":["The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden Hospital, Sutton, United Kingdom; M. D. Anderson Cancer Center, Houston, TX; Royal Marsden Hospital, Sutton, United Kingdom; Duke University Medical Centre, Durham, NC; GlaxoSmithKline, Research Triangle Park, NC","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210121186","https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"2040","last_page":"2040"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":1.0},{"id":"https://openalex.org/keywords/vegfr-inhibition","display_name":"VEGFR inhibition","score":0.6259999871253967},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.6600000262260437},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5550000071525574},{"id":"https://openalex.org/keywords/enzyme-inducing-anticonvulsants","display_name":"enzyme-inducing anticonvulsants","score":0.9120000004768372},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9139999747276306},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.7720000147819519},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4560000002384186},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8873558044433594},{"id":"https://openalex.org/C2778439243","wikidata":"https://www.wikidata.org/wiki/Q7157043","display_name":"Pazopanib","level":4,"score":0.6708523631095886},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6047965288162231},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.5924110412597656},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5243083238601685},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5231612920761108},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.48264795541763306},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.47953248023986816},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4504481554031372},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4411526322364807},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.42146602272987366},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.369562566280365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32990363240242004},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.29488062858581543},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2668984532356262},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.18037888407707214},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.13517048954963684},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.07746782898902893},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.2040","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.2040","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.2040","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2155798001","https://openalex.org/W2164323018","https://openalex.org/W4379335849","https://openalex.org/W4392246308","https://openalex.org/W2063983090","https://openalex.org/W2590278846","https://openalex.org/W2040176056","https://openalex.org/W2026519765","https://openalex.org/W2600955245","https://openalex.org/W2990276604"],"abstract_inverted_index":{"2040":[0],"Background:":[1],"Pazopanib":[2],"(paz)":[3],"is":[4,17],"an":[5,18],"oral":[6,19],"angiogenesis":[7],"inhibitor":[8,22],"targeting":[9],"VEGFR,":[10,31],"PDGFR,":[11,32],"and":[12,14,26,33,54,94,104,137,180,209,218,231,250,263,307,327,361,365,379],"c-kit;":[13],"lapatinib":[15],"(lap)":[16],"tyrosine":[20],"kinase":[21],"of":[23,30,52,68,102,121,129,150,156,278,286,292,331,348],"EGFR":[24],"(ErbB1)":[25],"HER-2":[27],"(ErbB2).":[28],"Combination":[29],"ErbB1":[34],"inhibitors":[35],"may":[36],"provide":[37],"synergistic":[38],"antitumor":[39],"activity":[40],"in":[41,73,108,303,312,373,376],"malignant":[42],"glioma.":[43],"Phase":[44,62,295],"I":[45,296,378],"determined":[46],"the":[47,66,118,191,274,290,320],"optimally":[48],"tolerated":[49],"regimen":[50],"(OTR)":[51],"paz":[53,103,276,349,360],"lap":[55,105,284,353,362],"when":[56],"given":[57],"with":[58,86,95,342,346],"enzyme-inducing":[59],"anticonvulsants":[60],"(EIACs).":[61],"II,":[63,322],"which":[64,124],"evaluated":[65],"efficacy":[67],"daily":[69,153],"paz/lap":[70,122,151,335],"(400":[71],"mg/1000mg)":[72],"relapsed":[74],"grade":[75,87],"4":[76,90],"glioma":[77],"without":[78,368],"EIACs,":[79,93],"was":[80,115,281,301],"previously":[81],"reported.":[82],"Methods:":[83],"Patients":[84],"(pts)":[85],"3":[88,110,112,264,304],"or":[89],"glioma,":[91],"on":[92,188,319],"adequate":[96],"organ":[97],"function":[98],"were":[99,106,140,215,237,371],"eligible.":[100],"Doses":[101],"escalated":[107],"a":[109,267,338,343],"+":[111],"design.":[113],"OTR":[114,345],"defined":[116],"as":[117],"highest":[119],"dose":[120,133,261,268],"at":[123,148,323],"no":[125],"more":[126],"than":[127],"1":[128,242,248,257],"6":[130],"pts":[131,144,260,265,305,314,317,375],"had":[132,266],"limiting":[134],"toxicity":[135],"(DLT)":[136],"target":[138,275,291],"concentrations":[139],"achieved.":[141],"Results:":[142],"32":[143],"have":[145],"been":[146],"enrolled":[147],"doses":[149],"(mg,":[152],"unless":[154],"specified)":[155],"200/1500":[157],"(N":[158,162,167,172,177,184],"=":[159,163,168,173,178,185],"4),":[160],"800/1500":[161],"6),":[164,179],"800/500":[165],"bid":[166,171,176,183],"5),":[169],"800/750":[170],"7),":[174],"800/1000":[175],"600":[181,271,350],"bid/1000":[182,272],"4).":[186],"Data":[187],"28":[189],"pts:":[190],"most":[192],"common":[193],"adverse":[194],"events":[195],"(AEs)":[196],"were:":[197],"fatigue":[198],"(25%);":[199,201],"diarrhea":[200],"headache":[202],"(21%);":[203],"ALT":[204,225],"increase":[205],"(18%);":[206,208],"nausea":[207],"insomnia":[210],"(14%).":[211,235],"Hepatobiliary":[212],"lab":[213],"abnormalities":[214],"reversible,":[216],"uncomplicated,":[217],"included:":[219],"AST":[220],"elevation":[221,226,234],"(11%),":[222],"hyperbilirubinemia":[223],"(7%),":[224],"(36%;":[227],"7%":[228],"Gr":[229],"3),":[230],"Alk":[232],"phos":[233],"DLTs":[236],"elevated":[238,244],"liver":[239],"enzymes":[240],"(800/1500;":[241],"pt),":[243],"lipase":[245],"(800/750":[246],"bid;":[247,256],"pt)":[249],"thrombocytopenia,":[251],"fatigue,":[252],"diarrhea,":[253],"confusion":[254],"(800/1000":[255],"pt).":[258],"2":[259],"reduced":[262],"interruption.":[269],"At":[270],"bid,":[273],"Cmin":[277,285],"17.5":[279],"\u03bcg/mL":[280,288],"achieved;":[282],"median":[283],"0.447":[287],"approached":[289],"0.5":[293],"\u03bcg/mL.":[294],"best":[297],"response":[298],"(MacDonald":[299],"criteria)":[300],"PR":[302],"(11%)":[306],"SD":[308],"\u2265":[309],"8":[310],"weeks":[311],"5":[313],"(18%).":[315],"Two":[316],"remain":[318],"phase":[321,377],"21":[324],"months":[325,329],"(PR)":[326],"23":[328],"(CR)":[330],"therapy.":[332],"Conclusions:":[333],"The":[334],"combination":[336],"has":[337],"manageable":[339],"safety":[340],"profile":[341],"preliminary":[344],"EIACs":[347,357],"mg":[351,355],"bid/":[352],"1000":[354],"bid.":[356],"decreased":[358],"plasma":[359],"concentrations.":[363],"Responses":[364],"lengthy":[366],"periods":[367],"disease":[369],"progression":[370],"seen":[372],"some":[374],"II.":[380],"[Table:":[381],"see":[382],"text]":[383]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}